Ring BJ[au] - Search Results

Year	Number of Results
1979	2
1981	1
1984	2
1986	1
1987	2
1988	1
1989	3
1990	2
1993	1
1994	2
1995	2
1996	4
1997	1
1998	4
1999	5
2000	3
2001	2
2002	4
2003	1
2005	2
2006	2
2010	1
2011	5
2012	1
2013	1
2015	1
2019	1
2020	1
2022	0

1

Clinical pharmacokinetics of atomoxetine.

Sauer JM, Ring BJ, Witcher JW. Sauer JM, et al. Among authors: ring bj. Clin Pharmacokinet. 2005;44(6):571-90. doi: 10.2165/00003088-200544060-00002. Clin Pharmacokinet. 2005. PMID: 15910008 Review.

2

Low-Turnover Drug Molecules: A Current Challenge for Drug Metabolism Scientists.

Hutzler JM, Ring BJ, Anderson SR. Hutzler JM, et al. Among authors: ring bj. Drug Metab Dispos. 2015 Dec;43(12):1917-28. doi: 10.1124/dmd.115.066431. Epub 2015 Sep 11. Drug Metab Dispos. 2015. PMID: 26363026 Review.

3

The human drug metabolizing cytochromes P450.

Wrighton SA, VandenBranden M, Ring BJ. Wrighton SA, et al. Among authors: ring bj. J Pharmacokinet Biopharm. 1996 Oct;24(5):461-73. doi: 10.1007/BF02353474. J Pharmacokinet Biopharm. 1996. PMID: 9131485 Review.

4

Danger in the vapor? ECMO for adolescents with status asthmaticus after vaping.

Bradford LE, Rebuli ME, Ring BJ, Jaspers I, Clement KC, Loughlin CE. Bradford LE, et al. Among authors: ring bj. J Asthma. 2020 Nov;57(11):1168-1172. doi: 10.1080/02770903.2019.1643361. Epub 2019 Jul 27. J Asthma. 2020. PMID: 31352844

5

Present and future in vitro approaches for drug metabolism.

Ekins S, Ring BJ, Grace J, McRobie-Belle DJ, Wrighton SA. Ekins S, et al. Among authors: ring bj. J Pharmacol Toxicol Methods. 2000 Jul-Aug;44(1):313-24. doi: 10.1016/s1056-8719(00)00110-6. J Pharmacol Toxicol Methods. 2000. PMID: 11274898 Review.

6

Predicting drug interactions and pharmacokinetic variability with in vitro methods: the olanzapine experience.

Wrighton SA, Ring BJ. Wrighton SA, et al. Among authors: ring bj. Drug Metab Rev. 1999 Feb;31(1):15-28. doi: 10.1081/dmr-100101905. Drug Metab Rev. 1999. PMID: 10065363 Review. No abstract available.

7

In vitro methods for assessing human hepatic drug metabolism: their use in drug development.

Wrighton SA, Vandenbranden M, Stevens JC, Shipley LA, Ring BJ, Rettie AE, Cashman JR. Wrighton SA, et al. Among authors: ring bj. Drug Metab Rev. 1993;25(4):453-84. doi: 10.3109/03602539308993982. Drug Metab Rev. 1993. PMID: 8313838 Review. No abstract available.

8

The use of in vitro metabolism techniques in the planning and interpretation of drug safety studies.

Wrighton SA, Ring BJ, VandenBranden M. Wrighton SA, et al. Among authors: ring bj. Toxicol Pathol. 1995 Mar-Apr;23(2):199-208. doi: 10.1177/019262339502300214. Toxicol Pathol. 1995. PMID: 7569675 Review.

9

Disposition and metabolism of semagacestat, a {gamma}-secretase inhibitor, in humans.

Yi P, Hadden C, Kulanthaivel P, Calvert N, Annes W, Brown T, Barbuch RJ, Chaudhary A, Ayan-Oshodi MA, Ring BJ. Yi P, et al. Among authors: ring bj. Drug Metab Dispos. 2010 Apr;38(4):554-65. doi: 10.1124/dmd.109.030841. Epub 2010 Jan 14. Drug Metab Dispos. 2010. PMID: 20075192

10

Autoactivation and activation of the cytochrome P450s.

Ekins S, Ring BJ, Binkley SN, Hall SD, Wrighton SA. Ekins S, et al. Among authors: ring bj. Int J Clin Pharmacol Ther. 1998 Dec;36(12):642-51. Int J Clin Pharmacol Ther. 1998. PMID: 9877001

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results